Sarcosine
CAS No. 107-97-1
Sarcosine( Sarcosine )
Catalog No. M17800 CAS No. 107-97-1
Sarcosine is a competitive inhibitor of the type I glycine transporter (GlyT1) and an N-methyl-D-aspartate receptor (NMDAR) co-agonist.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
100MG | 39 | In Stock |
|
200MG | 54 | In Stock |
|
500MG | 87 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSarcosine
-
NoteResearch use only, not for human use.
-
Brief DescriptionSarcosine is a competitive inhibitor of the type I glycine transporter (GlyT1) and an N-methyl-D-aspartate receptor (NMDAR) co-agonist.
-
DescriptionSarcosine is an amino acid intermediate in the metabolism of choline.
-
In Vitro——
-
In VivoAnimal Model:Albino Swiss mice weighing (25-30 g) Dosage:100 mg/kg, 200 mg/kg, 400 mg/kg, 800 mg/kg Administration:Intraperitoneal injection Result:Elevated the seizure threshold at doses of 400 mg/kg and 800 mg/kg in the MEST test in mice.
-
SynonymsSarcosine
-
PathwayAngiogenesis
-
Targetc-Kit
-
RecptorGlyT1|N-methyl-D-aspartate receptor
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number107-97-1
-
Formula Weight89.09
-
Molecular FormulaC3H7NO2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?H2O : 100 mg/mL (1122.46 mM)
-
SMILESCNCC(=O)O
-
Chemical NameGlycine, N-methyl-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Apatinib
Apatinib is an orally bioavailable, selective VEGFR2 inhibitor with IC50 of 1 nM.
-
Cistanoside A
Cistanoside A possesses protective activities on CCl4 induced hepatotoxicity in mice, which is involved with increasing free radicals clearing activities.
-
DCC-2618
DCC-2618 (Ripretinib, DCC2618) is a potent, oral inhibitor of singly and doubly mutated KIT with IC50 of WT (IC50=4 nM), V654A (8 nM), T670I (18 nM), D816H (5 nM).